NZ212531A - Stabilised, biologically-active form of procaterol - Google Patents
Stabilised, biologically-active form of procaterolInfo
- Publication number
- NZ212531A NZ212531A NZ212531A NZ21253185A NZ212531A NZ 212531 A NZ212531 A NZ 212531A NZ 212531 A NZ212531 A NZ 212531A NZ 21253185 A NZ21253185 A NZ 21253185A NZ 212531 A NZ212531 A NZ 212531A
- Authority
- NZ
- New Zealand
- Prior art keywords
- procaterol
- derivative
- carbon atoms
- moisture
- lauryl sulfate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Peptides Or Proteins (AREA)
- Quinoline Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/641,631 US4616022A (en) | 1984-08-17 | 1984-08-17 | Procaterol stabilization |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ212531A true NZ212531A (en) | 1988-02-12 |
Family
ID=24573198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ212531A NZ212531A (en) | 1984-08-17 | 1985-06-24 | Stabilised, biologically-active form of procaterol |
Country Status (14)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA875317B (en) * | 1986-08-01 | 1988-01-25 | Warner-Lambert Company | Transdermal compositions |
| US4687776A (en) * | 1986-10-24 | 1987-08-18 | Warner-Lambert Company | Drug stabilization |
| JPH01501797A (ja) * | 1987-03-16 | 1989-06-22 | ユニヴァーシティ オブ フロリダ | ３―置換―１―アルキルアミノ―２―プロパノールの不安定なケトン誘導体と、そのβ―アドレナリン作動効果遮断薬としての応用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1108320A (en) * | 1965-10-07 | 1968-04-03 | Shionogi & Co | Improvements in or relating to anti-microbial compositions |
| FR5129M (fr) * | 1966-01-18 | 1967-06-05 | Olivier Paul Gaudin | Medicaments a base d'alkylsulfate d'homomyrtenyloxy-2 diethylamino-1 ethane |
| US4026897A (en) * | 1974-01-31 | 1977-05-31 | Otsuka Pharmaceutical Company | 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxycarbostyril derivatives |
| BE896423A (fr) * | 1983-04-11 | 1983-08-01 | Ct Europ De Rech S Therapeutiq | Nouveaux sels liposolubles de doxycycline et leur preparation |
-
1984
- 1984-08-17 US US06/641,631 patent/US4616022A/en not_active Expired - Fee Related
-
1985
- 1985-06-18 DK DK275885A patent/DK275885A/da not_active Application Discontinuation
- 1985-06-18 CA CA000484326A patent/CA1265142A/en not_active Expired - Fee Related
- 1985-06-19 FI FI852431A patent/FI852431A7/fi not_active Application Discontinuation
- 1985-06-19 ZA ZA854636A patent/ZA854636B/xx unknown
- 1985-06-20 AU AU43881/85A patent/AU572306B2/en not_active Ceased
- 1985-06-24 NZ NZ212531A patent/NZ212531A/en unknown
- 1985-06-26 ES ES544571A patent/ES8701164A1/es not_active Expired
- 1985-07-04 GR GR851649A patent/GR851649B/el unknown
- 1985-07-10 JP JP60150329A patent/JPS6153267A/ja active Pending
- 1985-07-30 EP EP85305425A patent/EP0171969A3/en not_active Withdrawn
- 1985-08-14 PH PH32630A patent/PH20805A/en unknown
- 1985-08-14 PT PT80952A patent/PT80952B/pt not_active IP Right Cessation
- 1985-08-16 KR KR1019850005890A patent/KR900001175B1/ko not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GR851649B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1985-11-26 |
| EP0171969A3 (en) | 1987-11-04 |
| KR860001790A (ko) | 1986-03-22 |
| ZA854636B (en) | 1986-02-26 |
| AU572306B2 (en) | 1988-05-05 |
| US4616022A (en) | 1986-10-07 |
| CA1265142A (en) | 1990-01-30 |
| FI852431L (fi) | 1986-02-18 |
| EP0171969A2 (en) | 1986-02-19 |
| PT80952B (pt) | 1987-11-11 |
| DK275885A (da) | 1986-02-18 |
| KR900001175B1 (ko) | 1990-02-27 |
| PH20805A (en) | 1987-04-21 |
| ES8701164A1 (es) | 1986-11-16 |
| AU4388185A (en) | 1986-02-20 |
| DK275885D0 (da) | 1985-06-18 |
| FI852431A0 (fi) | 1985-06-19 |
| PT80952A (en) | 1985-09-01 |
| ES544571A0 (es) | 1986-11-16 |
| FI852431A7 (fi) | 1986-02-18 |
| JPS6153267A (ja) | 1986-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN85107838B (zh) | 稳定可注射的吡氧噻嗪溶液制备 | |
| SK282549B6 (sk) | Spôsob stabilizácie naloxonhydrochloridu | |
| EP0109103A2 (en) | Storage stable topical pharmaceutical compositions containing zinc erythromycin and t-butanol | |
| US3172816A (en) | Method of increasing the oil solubility of compounds and products thereof | |
| Bernasconi et al. | Nucleophilic addition to olefins. 21. Substituent and solvent effects on the reaction of benzylidene Meldrum's acids with piperidine and morpholine | |
| Landini et al. | Extractability and reactivity of hydroxide ion in low-polarity media under phase-transfer catalysis conditions: dramatic effect of the aqueous base concentration | |
| Li | Kinetics of reactions between iodine and histidine | |
| NZ212531A (en) | Stabilised, biologically-active form of procaterol | |
| Uekama et al. | Effects of cyclodextrins on the hydrolysis of prostacyclin and its methyl ester in aqueous solution | |
| US4221795A (en) | Pyridine derivative, its preparation and use | |
| AU736539B2 (en) | Method for producing stable acetylsalicylic acid solutions | |
| EP0159777A1 (en) | Stabilized 4-carbamoyl-imidazolium-5-olate | |
| US4742065A (en) | Salts of basic caffeine-8-ethers and their use as pharmaceuticals | |
| CA1136550A (en) | Pharmaceutical composition containing thymidine | |
| US4925931A (en) | N-homocysteine thiolactonyl retinamido cobalamin and methods of use thereof | |
| CA1208552A (en) | Storage stable topical pharmaceutical composition including nitrogen-containing stabilizers | |
| Ichikawa et al. | Kinetics of the Reaction of the Ethylene-Mercuric Acetate Addition Compound with Anisole | |
| JPH06107539A (ja) | チロシナーゼ阻害剤 | |
| JP2505513B2 (ja) | アズレン化合物の安定化法 | |
| JPS58502000A (ja) | 置換ピロ−ル | |
| Kaválek et al. | Kinetics of hydrolysis and rearrangements of S-acylthiouronium salts | |
| JPS5914005B2 (ja) | マイトマイシンｃの安定化法 | |
| US3133858A (en) | Stable thiobarbituric acid solution | |
| JPH0383926A (ja) | 軟膏組成物 | |
| Kevill et al. | Solvolysis of 1-adamantyl nitrate. A YONO2 scale and product partitioning in aqueous ethanol |